The liraglutide-treated group also had significantly ( p@ @ ) lower day-long glucose ( -@ % -LSB- -@ , -@ -RSB- vs -@ -LSB- -@ , @ -RSB- ) and NEFA concentrations ( -@ -LSB- -@ , -@ -RSB- vs -@ -LSB- -@ , @ -RSB- ) following mixed meals , whereas day-long insulin concentrations did not significantly differ as compared with placebo .